Cullen Building fisheye

$2.1M Grant from the Steven & Alexandra Cohen Foundation to support research of psilocybin and derivatives on aging

A team of researchers from Baylor College of Medicine and collaborating institutions led by Dr. Louise Hecker, clinical associate professor of medicine at Baylor, has been awarded a grant from the Steven & Alexandra Cohen Foundation, a Cohen Philanthropies organization led by philanthropist Alex Cohen, to evaluate the impact of psilocybin, the active compound in psychedelic mushrooms, and derivatives on aging.

The project will receive a $2.1M award over the next three years to evaluate the underlying molecular mechanisms and/or systemic effects that contribute to psilocybin’s clinical benefits that have been shown in numerous disease indications. The proposed studies build on the team’s recent groundbreaking discovery that psilocybin treatment affects multiple hallmarks of aging and leads to improved survival in aged mice. This project will explore – for the first time – whether psilocybin impacts human aging and whether it could be used to improve age-associated disease outcomes. 

Aging is a gradual process characterized by a decline in cell and tissue functions and an increased risk of various aging-related diseases, including neurodegenerative, cardiovascular, metabolic, musculoskeletal and immune system conditions. Although modern medicine has promoted human health, the elderly population is growing and a variety of chronic diseases have gradually become the most important causes of disability and death in elderly individuals. There is an increasingly urgent need for a more complete understanding of the molecular pathways and biological processes underlying ageing and age-related disorders. 

The main goal of this research is to identify a potent treatment to modulate the aging process and improve outcomes for age-associated diseases. Psilocybin has emerged as a promising candidate. Although overwhelming clinical evidence supports its efficacy for numerous neuro/psychiatric indications, little is known of the mechanisms that mediate psilocybin’s therapeutic benefits. This study aims at increasing our understanding of how psilocybin affects hallmarks of aging.

This project will employ innovative approaches, patient samples and novel cell and animal models, to systematically investigate mechanisms of action of psilocybin, while analyzing the effect of psilocybin on systemic human biomarkers. 

For the first time, the project will answer the question, does psilocybin impact human aging? No prior study has simultaneously and comprehensively assessed peripheral blood biomarkers of inflammation and aging in human psilocybin studies while evaluating the cellular and molecular underpinnings of its therapeutic short- and long-term effects in experimental models, both with cells in the lab and living individuals. 
This highly innovative translational approach could accelerate development for new treatments for age-related conditions.

“The whole of my independent research career has been focused on identifying age-dependent disease-causing mechanisms – processes that are dysfunctional in aging – and then developing therapeutic approaches to target that age-dependent dysfunction,” Hecker said. “However, this project has made me think differently about how we target age-associated disease. What if, instead of focusing on one target for one disease, we target aging itself? Could slowing the aging process improve outcomes for a host of age-associated diseases? That is exactly what this project will evaluate.” 

“People are taking psilocybin, yet very little is known about how it affects the body (outside the brain) – this is an urgent public health concern that needs to be addressed,” Hecker said. “We are very thankful to Alex Cohen and the Steven & Alexandra Cohen Foundation for their tremendous support of our project. Without it, research like this would not be possible.”

The team of investigators in this project includes Co-investigators, Drs. Kosuke Kato, Rachael Arey, Hongie Li, Shin, David Sheik-Hamad, Stacy Fischer, Anthony Haag, Cristian Corafa, James Clement and Sahin Ergun. 

Find an Expert

Let our media specialists help you find an expert in health, medicine, education, research and patient care.

Learn More

Research at Baylor

Read more about research at Baylor College of Medicine in From the Labs.

Learn More

Media Queries

During business hours call:
713-798-4710

After business hours call:
713-775-6912